U.S. Markets close in 1 hr 29 mins

Herbalife downgraded at Janney Capital

As previously reported, Janney Capital downgraded Herbalife to Neutral from Buy. The firm does not expect the controversy in the name to end anytime soon and expects uncertainty due to regulatory ambiguity or distributor independence to limit upside. Price target is $44.